Vietnam Medicinal Materials JSC (HSTC:DVM) 5-Year EBITDA Growth Rate: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTC:DVM Vietnam Medicinal Materials JSC HSTC:DVM
32 GF Score
Price ₫5,100.00
! 1 Warning Sign
View Full Analysis

What is Vietnam Medicinal Materials JSC 5-Year EBITDA Growth Rate?

Vietnam Medicinal Materials JSC HSTC:DVM -1.92% 32 5-Year EBITDA Growth Rate is 0.00% as of . 20. GuruFocus rates HSTC:DVM with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Vietnam Medicinal Materials JSC's EBITDA per Share for the six months ended in . 20 was ₫0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Vietnam Medicinal Materials JSC  (HSTC:DVM) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Vietnam Medicinal Materials JSC 5-Year EBITDA Growth Rate Related Terms

HSTC:DVM vs ZTS, UTHR, VTRS: 5-Year EBITDA Growth Rate Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vietnam Medicinal Materials JSC 5-Year EBITDA Growth Rate vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate falls into.


HSTC:DVM
32GF Score
Vietnam Medicinal Materials JSC HSTC:DVM
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vietnam Medicinal Materials JSC 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Vietnam Medicinal Materials JSC (HSTC:DVM) has a 5-Year EBITDA Growth Rate of 0.00% as of . 20. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vietnam Medicinal Materials JSC and its competitors.
Is Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate too high?
Vietnam Medicinal Materials JSC's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Vietnam Medicinal Materials JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate compare to ZTS and UTHR?
Vietnam Medicinal Materials JSC's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Drug Manufacturers company?
A good 5-Year EBITDA Growth Rate depends on the Drug Manufacturers industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vietnam Medicinal Materials JSC and its competitors. Vietnam Medicinal Materials JSC's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vietnam Medicinal Materials JSC stock overvalued right now?
Vietnam Medicinal Materials JSC (HSTC:DVM) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. Vietnam Medicinal Materials JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Vietnam Medicinal Materials JSC (HSTC:DVM), the current 5-Year EBITDA Growth Rate is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vietnam Medicinal Materials JSC Business Description

Address Zone 8, Phu Ninh Commune, Phu Ninh District, Phu Tho Province, Phu Ninh, VNM
Vietnam Medicinal Materials JSC is a company specializing in clean medicinal herbs and is committed to pharmaceuticals and health food products derived from natural medicinal herbs, with product quality as a top priority. Its business areas are the production and wholesale of medicinal herbs. Its activities include manufacturing and trading of pharmaceuticals, cultivation and processing of medicinal herbs, dietary supplements, wholesale and retail of medical products, cosmetics and equipment, and import and export of goods traded by the company. Its products are developed from standardized medicinal herbs under controlled cultivation, harvesting and processing, combining traditional remedies with science under strict quality control.
32GF Score

Get the complete analysis for HSTC:DVM

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫5,100.00
Price